The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of treatment of residual disease after immunotherapy-based combinations on complete response rate in metastatic renal cell carcinoma.
 
Fabien Moinard-Butot
No Relationships to Disclose
 
Marine Oriel
No Relationships to Disclose
 
Thibault Tricard
Travel, Accommodations, Expenses - Janssen-Cilag
 
Roberto Luigi Cazzato
Honoraria - Bristol-Myers Squibb
 
Laure Pierard
Honoraria - Bristol Myers Squibb Foundation
Travel, Accommodations, Expenses - Ipsen; Pfizer
 
Victor Gaillard
No Relationships to Disclose
 
Pierre Werle
No Relationships to Disclose
 
Veronique Lindner
Honoraria - AstraZeneca; Bristol-Myers Squibb; Ipsen
Travel, Accommodations, Expenses - Ipsen; MSD; Pfizer
 
Sophie Martin
No Relationships to Disclose
 
Caroline Schuster
No Relationships to Disclose
 
Catherine Roy
No Relationships to Disclose
 
Mickael Burgy
Honoraria - Bristol Myers Squibb Foundation; MSD
Consulting or Advisory Role - Lilly
Travel, Accommodations, Expenses - Ipsen; Pfizer
 
Anne Anthony
No Relationships to Disclose
 
Cecile Bigot
No Relationships to Disclose
 
Philippe Boudier
No Relationships to Disclose
 
Aurelie Fritsch
No Relationships to Disclose
 
Gabriel G. Malouf
Consulting or Advisory Role - ipsen; MSD; Pfizer
Travel, Accommodations, Expenses - Ipsen
 
Herve Lang
Honoraria - Astellas Amgen BioPharama; Ipsen; Janssen-Cilag
Travel, Accommodations, Expenses - Ipsen; Janssen
 
Philippe Barthelemy
Honoraria - Astellas Pharma; BMS; IPSEN; Janssen-Cilag; Merck KGaA; MSD; Novartis; Pfizer; Seagen
Consulting or Advisory Role - Amgen; AstraZeneca; BMS; Eisai; ipsen; Janssen-Cilag; Merck KGaA; MSD Oncology; Pfizer
Travel, Accommodations, Expenses - Astellas Pharma; BMS; IPSEN; Janssen-Cilag; MSD; Pfizer